0001209191-15-031169.txt : 20150402 0001209191-15-031169.hdr.sgml : 20150402 20150402125051 ACCESSION NUMBER: 0001209191-15-031169 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150401 FILED AS OF DATE: 20150402 DATE AS OF CHANGE: 20150402 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zeltiq Aesthetics Inc CENTRAL INDEX KEY: 0001415336 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 270119051 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4698 Willow Road STREET 2: Suite 100 CITY: Pleasanton STATE: CA ZIP: 94588-2710 BUSINESS PHONE: (925) 474-2500 MAIL ADDRESS: STREET 1: 4698 Willow Road STREET 2: Suite 100 CITY: Pleasanton STATE: CA ZIP: 94588-2710 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DeBenedictis Leonard C CENTRAL INDEX KEY: 0001417977 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35318 FILM NUMBER: 15746424 MAIL ADDRESS: STREET 1: C/O RELIANT TECHNOLOGIES, INC. STREET 2: 464 ELLIS STREET CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-04-01 0 0001415336 Zeltiq Aesthetics Inc ZLTQ 0001417977 DeBenedictis Leonard C ZELTIQ AESTHETICS INC. C/O 4698 WILLOW ROAD SUITE 100 PLEASANTON CA 94588 0 1 0 0 Chief Technical Officer Common Stock 2015-04-01 4 M 0 2709 6.50 A 52537 D Common Stock 2015-04-01 4 S 0 2709 30.2224 D 49828 D Stock Option (Right to Buy) 6.50 2015-04-01 4 M 0 2709 0.00 D 2022-10-07 Common Stock 2709 51458 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 18, 2014. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.04 to $30.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. 25% of the total number of shares subject to the option vested on October 8, 2013, and the remainder vests in equal monthly installments over a 36-month period thereafter, subject to the Reporting Person's continued service to the Issuer. /s/ Sergio Garcia, Attorney-in-Fact 2015-04-02